Author:
Sun Kaiwen,Müller Marietta,Macfarlane Catriona,Harris Mark,Tuplin Andrew
Abstract
AbstractChikungunya virus (CHIKV) is a re-emerging, pathogenic alphavirus that is transmitted to humans byAedes spp. mosquitoes—causing fever and debilitating joint pain, with frequent long-term health implications and high morbidity. The CHIKV lifecycle is poorly understood and specific antiviral therapeutics or vaccines are lacking. In the current study, we identify host cell Musashi RNA binding protein-2 (MSI-2) as a proviral factor. MSI-2 depletion and small molecule inhibition assays, demonstrated that MSI-2 is required for efficient CHIKV genome. Depletion of both MSI-2 and MSI-1 homologues resulted in a synergistic increase in CHIKV inhibition, suggesting redundancy in their proviral function. EMSA competition studies demonstrated that MSI-2 interacts specifically with an RNA binding motif within the 5’ untranslated region (5’UTR) of CHIKV and reverse genetic analysis showed that mutation of the binding motif inhibited genome replication and blocked rescue of mutant virus. For the first time, this study identifies the proviral role of MSI RNA binding proteins in the replication of the CHIKV genome, providing important new insight into mechanisms controlling replication of this significant human pathogen and offers the potential of a new therapeutic target.
Publisher
Cold Spring Harbor Laboratory